NCCN Hematology Congress 2017: Dr. Wierda on CLL (chronic lymphocytic leukemia) patients that progress on ibrutinib
Genetic tests can be important tools after an initial cancer diagnosis, helping doctors ensure the absolute best treatment available for a specific patient with a specific kind of cancer.
To follow-up on the Facebook chat I had at the ASH meeting last December, I will be hosting another Facebook Live Interactive workshop on the importance of genetic testing before treatment in CLL. I will be broadcasting from the 17th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) being held in New York City.
Join me, ask questions and cheer me along at 3:45 PM ET on this Saturday, May 13th.
Your link to join is https://www.facebook.com/CLLsociety/
I look forward to your questions and to hearing your thoughts.
Stay strong.
We are all in this together.
Brian Koffman, MD 5-12-17
Related posts